Members |
acceptabilityId |
3-hydroxytetradecanedioate |
Preferred (foundation metadata concept) |
3-hydroxytetradecanedioate (substance) |
Preferred (foundation metadata concept) |
3-hydroxytetradecanoylcarnitine |
Preferred (foundation metadata concept) |
3-hydroxytetradecanoylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-hydroxytetradecenoylcarnitine |
Preferred (foundation metadata concept) |
3-hydroxytetradecenoylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-hydroxyvalerate |
Preferred (foundation metadata concept) |
3-hydroxyvalerate (substance) |
Preferred (foundation metadata concept) |
3-indolelactate |
Acceptable (foundation metadata concept) |
3-isopropylmalate dehydratase |
Preferred (foundation metadata concept) |
3-isopropylmalate dehydratase (substance) |
Preferred (foundation metadata concept) |
3-isopropylmalate dehydrogenase |
Preferred (foundation metadata concept) |
3-isopropylmalate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3-keto n-valerate |
Preferred (foundation metadata concept) |
3-keto n-valerate (substance) |
Preferred (foundation metadata concept) |
3-keto, 2-methylvalerate |
Preferred (foundation metadata concept) |
3-keto, 2-methylvalerate (substance) |
Preferred (foundation metadata concept) |
3-keto-L-gulonate dehydrogenase |
Acceptable (foundation metadata concept) |
3-ketoacyl-CoA thiolase |
Acceptable (foundation metadata concept) |
3-ketobutyric acid |
Acceptable (foundation metadata concept) |
3-ketogulonate dehydrogenase |
Acceptable (foundation metadata concept) |
3-ketovalidoxylamine C-N-lyase |
Preferred (foundation metadata concept) |
3-ketovalidoxylamine C-N-lyase (substance) |
Preferred (foundation metadata concept) |
3-mercapto-1,2-propanediol |
Acceptable (foundation metadata concept) |
3-mercaptopyruvate sulfurtransferase |
Preferred (foundation metadata concept) |
3-mercaptopyruvate sulfurtransferase (substance) |
Preferred (foundation metadata concept) |
3-methoxy-4,5- methylenedioxyamphetamine |
Acceptable (foundation metadata concept) |
3-methoxy-4-hydroxyphenylglycol |
Acceptable (foundation metadata concept) |
3-methoxy-o-desmethylencainide |
Acceptable (foundation metadata concept) |
3-methoxy-pregnenolone |
Preferred (foundation metadata concept) |
3-methoxy-pregnenolone (substance) |
Preferred (foundation metadata concept) |
3-methoxyaniline |
Acceptable (foundation metadata concept) |
3-methoxytyramine |
Preferred (foundation metadata concept) |
3-methoxytyramine (substance) |
Preferred (foundation metadata concept) |
3-methyl histidine |
Preferred (foundation metadata concept) |
3-methyl histidine (substance) |
Preferred (foundation metadata concept) |
3-methyl indole |
Acceptable (foundation metadata concept) |
3-methyl,4-hydroxymandelate |
Preferred (foundation metadata concept) |
3-methyl,4-hydroxymandelate (substance) |
Preferred (foundation metadata concept) |
3-methyl-1-butanol |
Acceptable (foundation metadata concept) |
3-methyl-1-pentyn-3-ol |
Acceptable (foundation metadata concept) |
3-methyl-2-oxobutanoate dehydrogenase (lipoamide) kinase |
Preferred (foundation metadata concept) |
3-methyl-2-oxobutanoate dehydrogenase (lipoamide) kinase (substance) |
Preferred (foundation metadata concept) |
3-methyl-2-oxobutanoate dehydrogenase (lipoamide)-phosphatase |
Preferred (foundation metadata concept) |
3-methyl-2-oxobutanoate dehydrogenase (lipoamide)-phosphatase (substance) |
Preferred (foundation metadata concept) |
3-methyl-2-oxobutanoate hydroxy-methyltransferase |
Preferred (foundation metadata concept) |
3-methyl-2-oxobutanoate hydroxy-methyltransferase (substance) |
Preferred (foundation metadata concept) |
3-methyladipate |
Preferred (foundation metadata concept) |
3-methyladipate (substance) |
Preferred (foundation metadata concept) |
3-methylbutan-1-ol |
Preferred (foundation metadata concept) |
3-methylbutan-1-ol (substance) |
Preferred (foundation metadata concept) |
3-methylbutan-2-one |
Preferred (foundation metadata concept) |
3-methylbutan-2-one (substance) |
Preferred (foundation metadata concept) |
3-methylbutanal |
Preferred (foundation metadata concept) |
3-methylbutanal (substance) |
Preferred (foundation metadata concept) |
3-methylcrotonate |
Acceptable (foundation metadata concept) |
3-methylcrotonic acid |
Acceptable (foundation metadata concept) |
3-methylcrotonyl carnitine |
Preferred (foundation metadata concept) |
3-methylcrotonyl carnitine (substance) |
Preferred (foundation metadata concept) |
3-methylcrotonyl coenzyme A carboxylase |
Preferred (foundation metadata concept) |
3-methylcrotonyl coenzyme A carboxylase (substance) |
Preferred (foundation metadata concept) |
3-methylcrotonyl-CoA carboxylase |
Acceptable (foundation metadata concept) |
3-methylcrotonylglycine |
Preferred (foundation metadata concept) |
3-methylcrotonylglycine (substance) |
Preferred (foundation metadata concept) |
3-methyleneoxindole reductase |
Preferred (foundation metadata concept) |
3-methyleneoxindole reductase (substance) |
Preferred (foundation metadata concept) |
3-methylfentanyl |
Preferred (foundation metadata concept) |
3-methylfentanyl (substance) |
Preferred (foundation metadata concept) |
3-methylglutaconate |
Preferred (foundation metadata concept) |
3-methylglutaconate (substance) |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 5 |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 5 (disorder) |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 7 |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 7 (disorder) |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 8 |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 8 (disorder) |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 9 |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type 9 (disorder) |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome (disorder) |
Preferred (foundation metadata concept) |
3-methylglutaconic aciduria type VII |
Acceptable (foundation metadata concept) |
3-methylglutaconic aciduria, cataract, neurologic involvement, neutropenia syndrome |
Acceptable (foundation metadata concept) |
3-methylglutaconic aciduria, epilepsy, spasticity, severe intellectual disability syndrome |
Acceptable (foundation metadata concept) |
3-methylglutaconyl coenzyme A hydratase |
Acceptable (foundation metadata concept) |
3-methylglutaconyl-CoA hydratase |
Acceptable (foundation metadata concept) |
3-methylglutarate |
Preferred (foundation metadata concept) |
3-methylglutarate (substance) |
Preferred (foundation metadata concept) |
3-methylglutarylcarnitine |
Preferred (foundation metadata concept) |
3-methylglutarylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-methylhistidine |
Acceptable (foundation metadata concept) |
3-methylhistidine measurement |
Preferred (foundation metadata concept) |
3-methylhistidine measurement (procedure) |
Preferred (foundation metadata concept) |
3-methylindole |
Acceptable (foundation metadata concept) |
3-methylpentane |
Preferred (foundation metadata concept) |
3-methylpentane (substance) |
Preferred (foundation metadata concept) |
3-methylquercetin 7-O-methyltransferase |
Preferred (foundation metadata concept) |
3-methylquercetin 7-O-methyltransferase (substance) |
Preferred (foundation metadata concept) |
3-o-Methyldopa measurement |
Preferred (foundation metadata concept) |
3-o-Methyldopa measurement (procedure) |
Preferred (foundation metadata concept) |
3-oxo-5alpha-steroid delta^4^-dehydrogenase |
Acceptable (foundation metadata concept) |
3-oxo-5beta-steroid delta^4^-dehydrogenase |
Preferred (foundation metadata concept) |